SGK2 and breast cancer: Recent studies have reported that inhibiting ferroptosis promotes the metastasis of breast cancer, clear cell renal cell carcinoma, and melanoma [14–16, 25]; therefore, we presumed that the increase of SGK2 in facilitating PCa metastasis may be mediated by inhibiting ferroptosis (Fig. 2A).